1[1]Merlini PA,Serruys PW.Frontiers in interventional cardiology[J].Circulation,1994,90 (5):61-68.
2[2]Savonittos P,Bowles NE,Cunningham L.Molecular prokes for detection of persisting enterovirus infection of human heart and their prognostic value[J].Eur Heart J,1997,18[Suppl 2]:812-815.
3[3]Antman EM,Rich J,Edwards W,et al.The Primary Prevention of Coronary Heart Disease in Women[J].N Engl J Med,1996,335(6):1342-1349.
5[5]Califf RM,Bodey GP.P-wave analysis in myocardial infarction,pulmonary edema and embolism[J].Am J Heart,1999,20(6):20-25.
6[6]Braunwald G.Primary stent implantation without coumadin in acute myocardial infarction[J].Am Heart J,1999,82[Suppl 1]:15-17.
7[7]Cohen M,Vaughan DE.Effects of enalapril in mortality in severe congestive heart failure results of the Cooperative North Scandinavian Enalapril Suvial Study.N Engl J Med,1997,337(4):447-452.
8[8]Theroux P,Cote G,Lesperance S.Probucol and multivitanmls in the prevention of restenosis after coronary angioplasty[J].N Engl J Med,1998,319(20):1105-1111.
9[9]Buchanan MR,Adams DH.Heterotopic heart transplantation:experimental development and clinical experience[J].Eur J Cardiothorac Surg,1995,11 (2):221-227.
10[10]Davices MJ,Peter T,Clake ED.Reduction of enzyme levels by proprdnolol after acute myocardial infarction[J]-Circulation,1984,310 (7):1130-1137.
